Pharmaceuticals Market Research Reports & Industry Analysis
Filter your search
Research Assistance
Pharmaceuticals Industry Research & Market Reports
-
Global Hyperphosphatemia Drug Market Forecast 2017-2025
...be worth $8647 million by the year 2025. Increasing prevalence of chronic diseases, unmet medical needs, a high proportion of the elderly population and the rise in public awareness are the major drivers for the ... Read More
-
North America Hyperphosphatemia Drug Market Forecast 2017-2025
...the market with an anticipated increase in the revenue from $721 million in 2017 to $2470 million by 2025. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. ... Read More
-
Asia Pacific Hyperphosphatemia Drug Market Forecast 2017-2025
...period of 2017-2025 and generate $ 2445 million by the end of 2025. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. The growing prevalence of such chronic ... Read More
-
Europe Hyperphosphatemia Drug Market Forecast 207-2025
...increase from $625 million in 2017 to $2239 million by the end of 2025. Rising elderly citizenry, altering dietary habits and surging cases of osteoporosis are responsible for the expansion of the hyperphosphatemia drug market. ... Read More
-
Ukraine Pharmaceuticals and Healthcare Report Q3 2017
...and affordability of treatments;however the unstable political environment poses significant downside risk to this scenario. Headline Expenditure Projections Pharmaceuticals: UAH54.0bn (USD2.10bn) in 2016 to UAH64.9bn (USD2.38bn) in 2017; +20.2% inlocal currency terms and +13.1% in ... Read More
-
Germany Pharmaceuticals and Healthcare Report Q3 2017
...of cost-containmentmeasures, including manufacturer rebates, which will put a lid on their local revenues. Headline Expenditure Projections Pharmaceuticals: EUR58.33bn (USD60.80bn) in 2016 to EUR55.55bn (USD58.33bn) in 2017; +1.1%in local currency terms and -4.1% in US ... Read More
-
Serbia Pharmaceuticals and Healthcare Report Q3 2017
...and healthcare expenditure. Headline Expenditure ProjectionsPharmaceuticals: RSD92.1bn (USD822mn) in 2016 to RSD94.2bn (USD803mn) in 2017; +2.3% in localcurrency terms and -2.3% in US dollar terms. Forecast unchanged from previous quarter.Healthcare: RSD423.4bn (USD3.78bn) in 2016 to ... Read More
-
Colombia Pharmaceuticals and Healthcare Report Q3 2017
...high burden of both communicable and non-communicabledisease. Headline Expenditure Projections Pharmaceuticals: COP9,581bn (USD3.14bn) in 2016 to COP10,092bn (USD3.54bn) in 2017; +5.3% inlocal currency and +12.9% in US dollars. Forecast broadly unchanged from previous quarter. Healthcare: ... Read More
-
Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the ... Read More
-
France Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
Italy Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
Japan Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
Croatia Pharmaceuticals and Healthcare Report Q3 2017
...unemployed. Given the country's need to reduce its fiscaldeficit, we foresee a shift towards increasing private healthcare contributions. Headline Expenditure Projections Pharmaceuticals: HRK6.85bn (USD1.01bn) in 2016 to HRK6.98bn (USD937mn) in 2017; 2.0% inlocal currency and ... Read More
-
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2017
...support rising demand for chronic diseasetreatment and higher-value medicines. That said, the relatively small drug market by regional standards,together with an unattractive policy environment and drug pricing controls, will continue to make of SriLanka a ... Read More
-
Global Rehabilitation Robots Market 2017-2021
...robots are employed for various human body activities supported by hands, legs, ankle, wrist, fingers and others. These robots are used by patients suffering from major body disorders like paralytic body parts. Technavio’s analysts forecast ... Read More
-
Germany Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
Spain Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
UK Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV ... Read More
-
US Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV ... Read More
-
Kuwait Pharmaceuticals and Healthcare Report Q3 2017
...as a parliament which has consistently blockedthe government's reform efforts. While these healthcare reforms are still likely to be implemented, changesto the election law reform mean they are vulnerable to lengthy delays as political tensions ... Read More
-
Slovakia Pharmaceuticals and Healthcare Report Q3 2017
...years. The country's parliament has adopted anexpansionary budget on the back of increasing revenues, which is owed to higher employment andincreases in wage. Headline Expenditure Projections Pharmaceuticals: EUR1.98bn (USD2.19bn) in 2016 to EUR2.06bn (USD2.16bn) in ... Read More
-
Competing in the Global Sexually-Transmitted Disease (STD)Testing Market, 2017-2021
...forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on ... Read More
-
Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H1 2017
...Mch 2 or CASP6 or EC 3.4.22.59) pipeline Target constitutes close to 5 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes. Caspase 6 (Apoptotic Protease Mch 2 ... Read More
-
Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H1 2017
...Integrin Associated Protein or Protein MER6 or CD47) pipeline Target constitutes close to 13 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Leukocyte Surface ... Read More
-
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H1 2017
...Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Proto-oncogene tyrosine-protein kinase MER is an enzyme encoded by the MERTK gene. It regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic ... Read More
